V-Bio Ventures
v-bio.ventures Direct investor
Life sciences venture capital fund backing therapeutic and drug development companies across Europe. Managing €186 million with approximately 30+ active portfolio companies.
V-Bio Ventures is a venture capital firm headquartered in Gent, Belgium, founded in 2015. It invests directly in companies, from seed to Series B, in life Sciences and therapeutics. €186 million under management and 30 portfolio companies, as it reports.
“True impact is not just in the investment, but in the journey we take together—guiding companies from breakthrough ideas to global solutions”
— V-Bio Ventures, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Gent, Belgium
- Invests in
- Europe
- Sectors
- Life Sciences, Therapeutics
- Founded
- 2015
- Assets under management
- €186 million
- Portfolio
- 30 companies
Team, as V-Bio Ventures publishes it
- Christina Takke Managing Partner
- Katja Rosenkranz Partner
- Martin Solleveld Finance Manager
- Mathias Falcenberg Venture Partner
- Shelley Margetson Managing Partner
- Ward Capoen Partner
- Willem Broekaert Managing Partner
- Tom Schwarz Advisor
Names and roles exactly as listed on v-bio.ventures. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 30 co-investors found.
- Gemma Frisius Fund 4 shared companies: protealis.com, aphea.bio, astrivax.com, augustinetx.com
- Kurma Partners 4 shared companies: avidicure.com, coavetx.com, corteriapharma.com, step-ph.com
- Innovation Industries 2 shared companies: protealis.com, aphea.bio
- BioGeneration Ventures 2 shared companies: avidicure.com, confotherapeutics.com
- BOM (Brabantse Ontwikkelings Maatschappij) 2 shared companies: avidicure.com, flindrtx.com
- Asabys Partners 2 shared companies: agomab.com, augustinetx.com
- Omnes Capital 2 shared companies: agomab.com, corteriapharma.com
- Seroba Life Sciences 2 shared companies: coavetx.com, sibyllabiotech.it
- Korys 1 shared company: protealis.com
- Sofinnova 1 shared company: munatherapeutics.com
and 20 more — the graph.
Where this comes from
Every fact above was read from a page V-Bio Ventures publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- https://www.v-bio.ventures/type, sector, geographies, stage, aum, portfolio_count, founded, hq_city, hq_country, thesis_quote, name, is_investor, layer, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote_page, description, people, status
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 132 · added 2026-08-27 · link last verified 2026-09-06 · confidence high
Similar investors
- Bioqube VenturesVenture capital · Seed – Series B · Brussels, Belgium
- Droia VenturesVenture capital · Seed – Series B · Mechelen, Belgium
- Astanor VenturesVenture capital · Seed – Growth · Brussels, Belgium
- Fortino CapitalVenture capital · Antwerp, Belgium
- Hummingbird VenturesVenture capital · Pre-seed – Growth · Belgium
- imec.xpandVenture capital · Seed – Series A · Leuven, Belgium